Publisher: Research Institute for Gastroenterology and Liver Diseases (RIGLD)
  • Register
  • Login

Gastroenterology and Hepatology from Bed to Bench

  • Home
  • Issues
    • Current
    • Archives
  • About
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Privacy Statement
    • Contact
  • For Authors
    • Submissions
    • Author Guidelines
    • Peer Review Process
  • Indexing & Abstracting
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol. 5 (2012): Supplement 1 -Winter
  4. Original Article

ISSN: 2008-2258

Supplement 1 -Winter
Vol. 5 (2012)

Using statistical models to assess medical cost of hepatitis C virus

  • Mohsen Vahedi
  • Asma Pourhoseingholi
  • Sara Ashtari
  • Mohamad Amin Pourhoseingholi
  • Maryam Karkhane
  • Bijan Moghimi-Dehkordi
  • Azadeh Safaee
  • Zahra Kimia
  • Seyed Moayed Alavian

Gastroenterology and Hepatology from Bed to Bench, Vol. 5 (2012),
https://doi.org/10.22037/ghfbb.v5i1.260 Published 14 March 2012

  • View Article
  • Download
  • Cite
  • Statastics
  • Share

Abstract

Aim: This study compared PR and NB in predicting HCV patient costs. The objective of this study was to predict the direct cost of the HCV patient in Iran.

Background: Hepatitis C virus (HCV) is a common and expensive infectious disease in Iran.

Cost associated with HCV and its complications has not been well characterized. Analysis of cost data is important in providing consistent information to aid budgeting decisions and certain statistical regression models need for prediction mean costs. Poisson regression (PR) and negative binomial regression (NB) are more common in cost prediction study.

Patients and methods: This study designed as a cross-sectional clinic base from 2001 to 2010. First treatment period of each patient bring in study. We evaluated the doctor visiting, drugs, and hospitalization and laboratory tests of patients. Cost per person per one treatment period estimated in purchasing power parity dollars (PPP$). The PR is one of the models from general linear models (GLM) for describing count outcomes. The NB is another model from (GLM) as an alternative to the PR model.

Results: According to Likelihood ratio test NB was found to be more appropriate than PR (P<0.001). Genotype, marriage, medication, and SVR were being significant. Genotype 3 versus 1 decreasing cost while marriage, consuming pegasys and SVR increasing.

Conclusion: choosing best model in cost data is important because of specific feature of this data. After fitting the best model, analyzing and predicting future cost for patient in different situation is possible.

Keywords:
  • Chronic hepatitis C
  • Costs
  • Predictive models
  • Poisson regression
  • Negative binomial regression
  • PDF

How to Cite

Vahedi, M., Pourhoseingholi, A., Ashtari, S., Pourhoseingholi, M. A., Karkhane, M., Moghimi-Dehkordi, B., Safaee, A., Kimia, Z., & Alavian, S. M. (2012). Using statistical models to assess medical cost of hepatitis C virus. Gastroenterology and Hepatology from Bed to Bench, 5(1). https://doi.org/10.22037/ghfbb.v5i1.260
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX
  • Abstract Viewed: 102 times
  • PDF Downloaded: 62 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Open Journal Systems
Keywords
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

GHFBB journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Print ISSN: 2008-2258
Online ISSN: 2008-4234

Support Contact: ghfbb.journal@gmail.com

 

GHFBB is an open-access journal and does not charge fees for authors who submit their articles and for readers who access PDF files of published articles.

The template of this website is designed by Sinaweb